Page 31 - Immunizations News Today

By Joe Hoppe 4basebio said Tuesday that it has received a grant from the Bill & Melinda Gates Foundation to advance its synthetic DNA and Hermes...

Pfizer's stock was down premarket as earnings hit by lower demand for its COVID products.

Pfizer, Moderna and Novavax are slated to deliver new single-strain Covid shots targeting the omicron subvariant XBB.1.5 in September.

He got us ‘out of Afghanistan’ (by surrendering to the Taliban).

By Yifan Wang Shares of Cansino Biologics rose in Hong Kong, as the regulatory approval for the Chinese biotech firm's vaccine gave investors a boost of...

Most cases were traced to known areas of risk within the country.

Most respiratory syncytial virus (RSV) cases occur among older age groups and the risk for hospitalization and death goes up by age. A new CDC report will help those making decisions about vaccination.

"It is important to weigh the oncological benefits with the adverse birth outcome risks."

After reports of necrosis at the injection site after the 23-valent pneumococcal vaccine, an FDA investigation has concluded that the benefits of the vaccine outweigh the risks.

Pfizer is among several drugmakers racing to develop the world's first shot targeting Group B strep disease, which kills thousands of infants each year.